\-\ Texto\\:\\ \ \(0\)\
\-\ t2\\ hyperintense\\ lesions\\ in\\ the\\ upper\\ thoracic\\ and\\ upper\\ cervical\\ spinal\\ cord\\.\\ \\ the\\ lesions\\ are\\ isointense\\ on\\ t1\\ and\\ on\\ t1\\ with\\ gadolinium\\.\ \(0\)\
\-\ lupus\\ myelitis\ \(1\)\
\-\ etiologies\\ for\\ transverse\\ myelitis\\ include\\ multiple\\ sclerosis\\,\\ sle\\,\\ other\\ connective\\ tissue\\ diseases\\,\\ sarcoidosis\\,\\ vasculitides\\,\\ idiopathic\\,\\ and\\ post\\-infectious\\.\ \(0\)\
\-\ 37\\ yo\\ woman\\ with\\ systemic\\ lupus\\ erythematosus\\ presents\\ with\\ progressive\\ weakness\\ and\\ malaise\\.\ \(1\)\
\-\ this\\ case\\ is\\ not\\ radiographically\\ unique\\ for\\ lupus\\ myelitis\\,\\ since\\ the\\ lesions\\ are\\ not\\ greater\\ than\\ 2\\ vertebral\\ bodies\\ in\\ length\\.\\ \\ given\\ that\\ the\\ lesions\\ do\\ not\\ enhance\\ \\(and\\ symptomatic\\ cord\\ lesions\\ in\\ ms\\ typically\\ do\\)\\,\\ ms\\ is\\ less\\ likely\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ myelitis\\:\\ 0\\.4079607137756195\ \(0\)\
\-\ lupus\\:\\ 0\\.35293670519153525\ \(0\)\
\-\ lesions\\:\\ 0\\.324180849923544\ \(0\)\
\-\ ms\\:\\ 0\\.21924220166684436\ \(0\)\
\-\ do\\:\\ 0\\.18714433141181938\ \(0\)\
\-\ cord\\:\\ 0\\.16736732086152364\ \(0\)\
\-\ vasculitides\\:\\ 0\\.15574856114004823\ \(0\)\
\-\ t1\\:\\ 0\\.1406797406806567\ \(0\)\
\-\ erythematosus\\:\\ 0\\.1340061756689672\ \(0\)\
\-\ not\\:\\ 0\\.1337033191131871\ \(0\)\
\-\ unique\\:\\ 0\\.1269473031267769\ \(0\)\
\-\ malaise\\:\\ 0\\.1250610410760074\ \(0\)\
\-\ upper\\:\\ 0\\.12065735947564094\ \(0\)\
\-\ sle\\:\\ 0\\.11982257104914533\ \(0\)\
\-\ connective\\:\\ 0\\.11723749678253781\ \(0\)\
\-\ and\\:\\ 0\\.11664057212070915\ \(0\)\
\-\ etiologies\\:\\ 0\\.11322938521945211\ \(0\)\
\-\ radiographically\\:\\ 0\\.1125804493075753\ \(0\)\
\-\ diseases\\:\\ 0\\.10372256293293695\ \(0\)\
\-\ length\\:\\ 0\\.10292282696756222\ \(0\)\
\-\ isointense\\:\\ 0\\.10215415667659128\ \(0\)\
\-\ enhance\\:\\ 0\\.10105438641474279\ \(0\)\
\-\ systemic\\:\\ 0\\.10018240519640498\ \(0\)\
\-\ bodies\\:\\ 0\\.0988625314002505\ \(0\)\
\-\ 37\\:\\ 0\\.09617998145406148\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.09563020243077484\ \(0\)\
\-\ idiopathic\\:\\ 0\\.09549511131145677\ \(0\)\
\-\ gadolinium\\:\\ 0\\.09406696078096587\ \(0\)\
\-\ the\\:\\ 0\\.09010558729819348\ \(0\)\
\-\ hyperintense\\:\\ 0\\.08980166096788822\ \(0\)\
\-\ transverse\\:\\ 0\\.0869830524705587\ \(0\)\
\-\ symptomatic\\:\\ 0\\.08680868330614255\ \(0\)\
\-\ progressive\\:\\ 0\\.08646448728908021\ \(0\)\
\-\ vertebral\\:\\ 0\\.08621021262892739\ \(0\)\
\-\ are\\:\\ 0\\.0856760990267913\ \(0\)\
\-\ thoracic\\:\\ 0\\.08436226767073951\ \(0\)\
\-\ in\\:\\ 0\\.08425291473959104\ \(0\)\
\-\ greater\\:\\ 0\\.08317148617262371\ \(0\)\
\-\ weakness\\:\\ 0\\.08239250012841626\ \(0\)\
\-\ since\\:\\ 0\\.08177719340413196\ \(0\)\
\-\ cervical\\:\\ 0\\.08085652637492845\ \(0\)\
\-\ sclerosis\\:\\ 0\\.08041177120551024\ \(0\)\
\-\ spinal\\:\\ 0\\.08016204206058442\ \(0\)\
\-\ typically\\:\\ 0\\.07925265825411308\ \(0\)\
\-\ given\\:\\ 0\\.07765943739363892\ \(0\)\
\-\ less\\:\\ 0\\.07680348681948032\ \(0\)\
\-\ yo\\:\\ 0\\.07052962032827736\ \(0\)\
\-\ for\\:\\ 0\\.06843446761388419\ \(0\)\
\-\ on\\:\\ 0\\.06819170975835506\ \(0\)\
\-\ likely\\:\\ 0\\.06746252358915639\ \(0\)\
\-\ include\\:\\ 0\\.06717076245052743\ \(0\)\
\-\ with\\:\\ 0\\.06631803181734053\ \(0\)\
\-\ t2\\:\\ 0\\.06495089941984615\ \(0\)\
\-\ than\\:\\ 0\\.06399626577886294\ \(0\)\
\-\ is\\:\\ 0\\.061833449199100395\ \(0\)\
\-\ tissue\\:\\ 0\\.05922152462978926\ \(0\)\
\-\ woman\\:\\ 0\\.05879544203408058\ \(0\)\
\-\ other\\:\\ 0\\.058627544762953995\ \(0\)\
\-\ case\\:\\ 0\\.05671660001720489\ \(0\)\
\-\ multiple\\:\\ 0\\.05521879757826888\ \(0\)\
\-\ presents\\:\\ 0\\.05430772840188984\ \(0\)\
\-\ that\\:\\ 0\\.048991660402460904\ \(0\)\
\-\ this\\:\\ 0\\.03879233077103881\ \(0\)\
